Howard McLeod, Pharm.D.
Medical Director, Geriatric Oncology
Lincoln Nadauld, M.D., Ph.D.
Chief, Precision Health, Intermountain
PMC's Science Policy Committee collaborates to develop and align medical practices and policies with the evolving base of evidence demonstrating the clinical and economic benefits of personalized medicine. The committee maintains two standing working groups focused on addressing clinical adoption challenges and improving value assessment frameworks.
» Science Policy
» Understanding and Delivering the Clinical and Economic Benefits of Personalized Medicine